Investor Portal
This information is confidential and intended for accredited investors evaluating Heyday Health. Please verify your identity to proceed.
By accessing this portal, you confirm you are an accredited investor as defined by SEC Rule 501. Information contained herein is confidential and may not be shared without written consent from Heyday, Inc.
Heyday Health — Investor Portal
Executive overview, financials, market analysis, and corporate documents
Modern Men's Health, Delivered
Heyday is a men's health platform redefining how men access hormone optimization, weight loss, and longevity care. We combine at-home diagnostics, telehealth consultations, and direct-to-door prescription delivery — all built around personalized treatment plans for men over 35.
Aging men are underserved by traditional healthcare. Most face declining testosterone, weight gain, low energy, and sexual dysfunction. Care is fragmented, inconvenient, or unavailable — and stigma prevents action.
Heyday provides an end-to-end digital experience: arm-based at-home blood testing, clinical consults via telemedicine, and monthly prescription fulfillment. Treatments include TRT, GLP-1s, ED medication, and performance supplements.
Subscription and a la carte pricing. Base subscription of $129/month with average add-ons of $71, totaling $225/month ARPU. Margins of 60%+ via compounding pharmacy partnerships and in-house clinical operations.
Revenue Projections
The financial model is built on conservative but scalable assumptions across subscriber growth, revenue, margin, and acquisition efficiency.
| Subscribers | MRR | ARR | Gross Profit/Mo | Annual GP |
|---|---|---|---|---|
| 100 | $22,500 | $270,000 | $13,500 | $162,000 |
| 250 | $56,250 | $675,000 | $33,750 | $405,000 |
| 500 | $112,500 | $1,350,000 | $67,500 | $810,000 |
| 1,000 | $225,000 | $2,700,000 | $135,000 | $1,620,000 |
| 2,500 | $562,500 | $6,750,000 | $337,500 | $4,050,000 |
Revenue
ARPU: $225/month ($129 base + $71 avg add-ons)
LTV
$1,800–$2,700+ (8–12 month avg retention)
CAC
$150–300 blended (decreasing with organic growth)
LTV:CAC
6–9x (improving with scale)
Current Gross Margin
60%+ via pharmacy scaling and fulfillment efficiency
Path to Improvement
- Pharmacy volume discounts at scale
- Lab cost reduction through panel bundling
- Higher upsell conversion (labs → TRT → GLP-1)
- CAC reduction via SEO content engine
Churn
Average monthly churn: 8–10% (industry avg 10–15%)
End-to-End Digital Health Platform
Step 1: At-Home Lab Collection
Arm-based collection device (not a fingerprick). No clinic visits or phlebotomist required. Sample collected at home in under 10 minutes and mailed back in a prepaid envelope. Easy, painless, and discreet — designed to reduce friction in diagnostics.
Step 2: Provider Consultation
Results reviewed by a licensed provider via secure video or asynchronous chat. Personalized treatment plans created based on lab results and symptom profile. Not a script mill — patients speak to real doctors and get real clinical care.
Step 3: Treatment Delivery
Medications delivered to the patient's door via partner pharmacies. Monthly auto-refill, reminders, and tracking. Custom compounding and brand options available.
| Product | Category | Pricing |
|---|---|---|
| Testosterone Cypionate 200mg/mL | TRT | $99–139/mo |
| Enclomiphene | TRT Alternative | Add-on |
| Semaglutide (compounded) | GLP-1 Weight Loss | $299+/mo |
| Tirzepatide (compounded) | GLP-1 Weight Loss | $349+/mo |
| Heyday Lab Kit (40+ biomarkers) | Diagnostics | $129/panel |
| Anastrozole | Estrogen Management | Included |
| HCG | Fertility Preservation | Add-on |
$5B+ Addressable Market, Growing 12% YoY
The men's health telehealth market sits at the intersection of several macro trends: rising awareness of testosterone deficiency, FDA momentum toward loosening TRT restrictions, the GLP-1 weight loss revolution, and the permanent shift to telehealth delivery.
Demographics
- Age: 38–50
- Income: $150K+
- Occupation: Entrepreneur, executive, sales
- Lifestyle: Gym 4–5x/week, supplement user
Psychographics
- Listens to: Huberman Lab, health podcasts
- Goals: Energy, mental clarity, muscle mass
- Pain points: Low T symptoms, no PCP support
- Products: Test Cyp, Enclomiphene, Peptides
Direct-response advertising combined with a high-converting quiz funnel, supported by automated follow-ups and a scalable telehealth platform.
Acquisition Channels
- Paid Social (Meta): Symptom-aware creative targeting men 35-55
- Google Ads: High-intent keyword capture (TRT online, low T treatment)
- SEO Content Engine: 60-page topical authority site driving organic traffic
- Influencer / Podcast: Health & fitness creators in the optimization space
- Referral Program: Patient incentives for word-of-mouth growth
Conversion Funnel
Onboarding begins with a short quiz that pre-qualifies leads. Prospects are guided through lab collection, provider consultation, and treatment enrollment with automated reminders at each stage. Current funnel conversion: quiz → enrollment averaging 8-12%.
Heyday positions as a premium men's health brand focused on optimization — not maintenance. We target users frustrated with low-touch care and commoditized prescriptions, offering deeper clinical experience and lifestyle-centric treatment bundles.
| Dimension | Heyday | Hims/Ro | TRT Nation | Gameday |
|---|---|---|---|---|
| Focus | Hormone + metabolic optimization | General men's health | TRT only | In-clinic + telehealth |
| At-Home Labs | ✓ 40+ biomarkers | Varies | ✗ | ✗ (in-clinic) |
| GLP-1 + TRT Combo | ✓ Integrated | Separate products | ✗ | ✓ |
| ARPU | $225 | ~$100 | ~$99 | Varies |
| Monitoring Included | ✓ | Varies | ✗ (extra) | ✓ |
Founding Team
Details available upon request during due diligence. The founding team combines clinical operations experience, digital health product development, and direct-to-consumer growth marketing expertise.
Key Competencies
- Healthcare operations and compliance (Article 28, HIPAA)
- Telehealth platform development and deployment
- Direct-response digital marketing and funnel optimization
- Clinical protocol design with licensed provider networks
- Pharmacy and fulfillment partnership management
Heyday is building an advisory board with expertise in men's health clinical research, DTC health brand scaling, telehealth regulatory compliance, and pharmacy/compounding operations. Inquiries welcome.
Operating Metrics
| Metric | Current | Target (12 mo) |
|---|---|---|
| Active Subscribers | Growing | 680 |
| MRR | Growing | $121,720 |
| ARR Run Rate | Growing | $1.46M |
| Gross Margin | 60%+ | 65% |
| Monthly Churn | 8-10% | <8% |
| CAC (Blended) | $150-300 | <$200 |
| LTV:CAC | 6-9x | 10x+ |
- Organic SEO: 60-page content site targeting 500K+ monthly search volume
- Product expansion: Peptides, ED, hair loss, supplement bundles
- Upsell engine: Labs → TRT → GLP-1 → full optimization stack
- Retention: Ongoing monitoring, dose optimization, provider relationship
- Referral program: Patient-driven word-of-mouth acquisition
Data Room
Documents available for review by verified accredited investors. Contact contact@heydaymd.com for access.
SAFE Terms
Heyday, Inc. is a Delaware corporation raising via SAFE (Simple Agreement for Future Equity). Terms, valuation cap, and minimum investment discussed directly with qualified investors. Contact contact@heydaymd.com to schedule a call.